Senior insider sale
Chief Scientific Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$36.8K
5.48K shares
What this filing means
ADLER ERIC plans to sell 5.48K shares of LEXEO THERAPEUTICS, INC. valued at approximately $36.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001959173-26-001140
Officer· Chief Scientific Officer
Since Nov 2023
5.48K
Shares to sell
$36.8K
Approx. market value
4.87K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/17/2026
4.87KTotal acquired4.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 4.87K | — |
| Total | 4.87K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
615.00
Market value
$5.7K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.87K
Market value
$31.1K
2/18/2026
Total
Units
5.48K
Value
$36.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 615.00 | $5.7K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 4.87K | $31.1K | NASDAQ | Planned |
| Total | 5.48K | $36.8K | ||